As COVID Recedes, New Challenges Arise
Key Points: In today’s Recommendations for Industry, we discuss how COVID-19 has impacted other areas of public health. Read more below. In the U.S., new
Author: TAG
Webmaster and Administrator of The Acheson Group website.
COVID Declining; Continuing to Impart Lessons for Infectious Disease Control
Key Points: In today’s Recommendations for Industry, we discuss the continued decline of COVID and the lessons it continues to impart for infectious disease (and
COVID Transitional Period Increases Masking Debate
Key Points: In today’s Recommendations for Industry, we discuss the current “transition” status of COVID-19, mask mandates, and recommendations. Read more below. Is the Coronavirus
TAG COVID Matrix Showing Encouraging Trends
Key Points: In today’s Recommendations for Industry, we discuss TAG’s matrix and the current trends of COVID and its variants. Read more below. As countries
Cliché but True: Keep Calm and Carry On
Key Points: In today’s Recommendations for Industry, we discuss the current progression of COVID and the flu and why keeping calm is the phrase of
TAG Holds Guarded Optimism for the Ebbing of Omicron
Key Points: In today’s Recommendations for Industry, we discuss our guarded optimism for the ebbing of Omicron. Read more below. OSHA Withdraws Its Workplace Vaccine
What Does an Endemic COVID Really Mean?
Key Points: In today’s Recommendations for Industry, we discuss the ebbing of Omicron and what a shift to an endemic COVID would really mean. Read
COVID Case Rates Following Predictable Pattern
Key Points: In today’s Recommendations for Industry, we discuss Omicron’s path across the US. Read more below. U.S. hospitals have been inundated with Omicron cases;
Build Your Systems for COVID’s Next Wave
Key Points: In today’s Recommendations for Industry, we discuss the business management of COVID’s next wave … whatever that may be. Read more below. As
Even Unrelated Vaccines Can Help Protect Against COVID-19
Key Points: In today’s Recommendations for Industry, we discuss new studies suggesting that flu shots, measles vaccines, and the common cold can cross-protect against COVID.
